Text Size

Measurement of Glycaemic Responses of Bakery and Confectionery Products (GIFA)

This study has been completed.
Sponsor:
Collaborator:
Fazer Bakeries Ltd.
Information provided by (Responsible Party):
Clinical Life Sciences Ltd.
ClinicalTrials.gov Identifier:
NCT01454219
First received: October 14, 2011
Last updated: February 14, 2012
Last verified: November 2011
History of Changes
  Purpose

This study aims to determine the glycemic index, glycemic load and insulin index of eleven Fazer bakery and confectionary products.


Condition Intervention
Healthy
 Other: Bakery and confectionary products

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Measurement of Glycaemic Responses of Bakery and Confectionery Products

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Clinical Life Sciences Ltd.:

Primary Outcome Measures:
  • Glycemic index (GI) [ Designated as safety issue: No ]
    The 2 hours glycemic responses to bakery and confectionery products (the incremental area under the glucose response curve, IAUC).


Secondary Outcome Measures:
  • Insulin index (II) [ Designated as safety issue: No ]
    The 2 hours insulinemic responses to bakery and confectionery products (the incremental area under the insulin response curve, IAUC).

  • Glycemic load (GL) [ Designated as safety issue: No ]

Enrollment: 14
Study Start Date: August 2011
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Bakery and confectionary products
    Control product: Glucose solution, Test products: 11 bakery and confectionary products
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • voluntarily given written consent for participation in research
  • healthy man or women, age between 18 ang 65 years
  • regular eating
  • Body Mass Index 18,5 - 24,9 kg/m2

Exclusion Criteria:

  • diabetes
  • gastrointestinal diseases
  • hepatic, kidney, pancreas or thyroid disease or disorder
  • arthritis
  • pregnancy or breast feeding
  • smoking
  • allergy
  • severe diseases
  • blood donation
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01454219

Locations
Finland
Clinical Life Sciences Ltd
Kajaani, Finland, 87100
Sponsors and Collaborators
Clinical Life Sciences Ltd.
Fazer Bakeries Ltd.
Investigators
Principal Investigator: Päivi Cheney, MD
Study Director: Tiina Suutari, M.Sc. Clinical Life Sciences Ltd.
  More Information

No publications provided

Responsible Party: Clinical Life Sciences Ltd.
ClinicalTrials.gov Identifier: NCT01454219     History of Changes
Other Study ID Numbers: GIFA
Study First Received: October 14, 2011
Last Updated: February 14, 2012
Health Authority: Finland: Ethics Committee

ClinicalTrials.gov processed this record on June 18, 2013